Search
Search Results
##search.searchResults.foundPlural##
-
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1999Suppl. Files: 921HTML: 590PDF: 785 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3296PDF: 965HTML: 3011 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6457PDF: 2198HTML: 14147Untitled: 220figure: 203 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2029PDF: 844HTML: 2212Table 1: 203Table 2: 219Table 3: 217Table 4: 219Table 5: 214Tble 6: 209Cover Letter: 229Greene Tab.7: 228 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4364PDF: 1566HTML: 469 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4303Suppl. Files: 1212PDF: 1130Html: 260 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2230PDF: 1976HTML: 522 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2288PDF: 752HTML: 2144Untitled: 247Untitled: 170Untitled: 201Untitled: 174Untitled: 192Untitled: 200Untitled: 205 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1906PDF: 1147HTML: 10750Untitled: 212 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4915PDF: 1860HTML: 2865Untitled: 251 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2569PDF: 1734HTML: 518 -
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3883PDF: 1641HTML: 8235Randi Fig: 204 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4285PDF: 2018HTML: 1956 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4057PDF: 1097HTML: 3896Untitled: 187Cneo. Fig.1: 125Untitled: 120Untitled: 145Untitled: 154 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4610PDF: 1781HTML: 1217 -
TYROSINE KINASE INHIBITORS AND PREGNANCY
3740PDF: 1720HTML: 2692 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2219PDF: 1036HTML: 4092Cover Letter: 241Figure 1: 255Figure 2: 248Table 1: 229 -
BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI
5486PDF: 2875HTML: 30406Antinori Tables 1,2,3: 390 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2502PDF: 1637HTML: 698 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1953PDF: 504HTML: 4037 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3674PDF: 1587HTML: 4498CoverLetter: 204Figure1: 221 -
-
IMMUNOLOGY OF TUBERCULOSIS
5742PDF: 2139HTML: 7359Untitled: 214 -
SOCIAL IMPLICATIONS OF MALARIA AND THEIR RELATIONSHIPS WITH POVERTY
6257PDF: 3435HTML: 9059Figure Malaria Ricci: 259 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2666PDF: 1069HTML: 5108Cover Letter: 185Figure 2: 185Figure 1: 192Figure 3: 217Figure 4: 188Figure Legend: 200Table 1: 214Table 2: 200Table 3: 200 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2563PDF: 1355HTML: 1821CoverLetter: 204 -
-
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8223PDF: 4437HTML: 7559 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
619PDF: 368Html: 32 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3707PDF: 2593HTML: 1615 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4855PDF: 1602HTML: 2263Untitled: 251Untitled: 264Untitled: 284Untitled: 235Untitled: 253 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
768PDF: 592Html: 138 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
195PDF: 182HTML: 48 -
UPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
2470PDF: 1471HTML: 2021







